SlideShare a Scribd company logo
1 of 2
Download to read offline
DESIGNING DEGENERATE PRIMERS
• Degenerate primers may be used to amplify DNA in situations where
only the protein sequence of a gene is known, or where the aim is to
isolate similar genes from a variety of species.
• A six or seven residue peptide sequence should be selected,
corresponding to an oligo of about 20 nucleotides.
• If the oligo is designed to amplify several similar protein sequences,
then the most conserved regions of the proteins need to be selected.
If some of the residues are not completely conserved, then the oligo
sequence will need to accommodate all possible codons of all amino acid
residues at that site (e.g. if one protein has an E at a particular site,
while all the others have a D, then the corresponding oligo sequence
will be GAN – see table overleaf).
• The peptide sequence should avoid amino acids that have a lot of
codons, such as leucine (L), arginine (R), and serine (S). Instead, aim
for regions that are rich in amino acids that have only one or two
possible codons (i.e. M, W, C, D, E, F, H, K, N, Q, Y – see table
overleaf).
• Inosine residues can pair with any nucleotide, and so can be used at
sites where there is complete degeneracy (i.e. substitute I for N in
the table below). This reduces the number of oligos that have to be
synthesised. Note that only some manufacturers use inosine, however.
• Try and avoid degeneracy at the 3’ end of the oligo (note that it is not
necessary to have whole codons), and especially avoid ending in inosine.
• The table overleaf may be used to help with primer design:
amino acid amino acid
symbol
nucleotide
sequence (with
complement (for
designing reverse
degeneracy) primers)
methionine M ATG TAC
tryptophan W TGG ACC
cysteine C TGY ACR
aspartic acid D GAY CTR
glutamic acid E GAR CTY
phenylalanine F TTY AAR
histidine H CAY GTR
lysine K AAR TTY
asparagine N AAY TTR
glutamine Q CAR GTY
tyrosine Y TAY ATR
inosine I ATH TAD
alanine A GCN CGN
glycine G GGN CCN
proline P CCN GGN
threonine T ACN TGN
valine V GTN CAN
leucine L YTN RAN
arginine R MGN KCN
serine S WSN WSN
Key to symbols:
R = A + G Y = C + T
M = A + C K = G + T
S = G + C
W = A + T
H = A + T + C D = G + A + T
B = G + T + C V = G + A + C
N = A + T + G + C

More Related Content

What's hot

transfection and invitro packaging of phage genome
transfection and invitro packaging of phage genometransfection and invitro packaging of phage genome
transfection and invitro packaging of phage genomeNOMI KhanS
 
DNA SEQUENCING METHODS AND STRATEGIES FOR GENOME SEQUENCING
DNA SEQUENCING METHODS AND STRATEGIES FOR GENOME SEQUENCINGDNA SEQUENCING METHODS AND STRATEGIES FOR GENOME SEQUENCING
DNA SEQUENCING METHODS AND STRATEGIES FOR GENOME SEQUENCINGPuneet Kulyana
 
Single Nucleotide Polymorphism (SNP)
Single Nucleotide Polymorphism (SNP)Single Nucleotide Polymorphism (SNP)
Single Nucleotide Polymorphism (SNP)amna munir
 
Synthesis of c dna
Synthesis of c dnaSynthesis of c dna
Synthesis of c dnaDUVASU
 
Telomere replication
Telomere replicationTelomere replication
Telomere replicationEmaSushan
 
Presentation on marker genes
Presentation on marker genesPresentation on marker genes
Presentation on marker genesTasmina Susmi
 
Expressed sequence tag (EST), molecular marker
Expressed sequence tag (EST), molecular markerExpressed sequence tag (EST), molecular marker
Expressed sequence tag (EST), molecular markerKAUSHAL SAHU
 
Rapid amplification of c-DNA ends
Rapid amplification of c-DNA endsRapid amplification of c-DNA ends
Rapid amplification of c-DNA endsLovnish Thakur
 

What's hot (20)

transfection and invitro packaging of phage genome
transfection and invitro packaging of phage genometransfection and invitro packaging of phage genome
transfection and invitro packaging of phage genome
 
Knockout mice
Knockout miceKnockout mice
Knockout mice
 
DNA SEQUENCING METHODS AND STRATEGIES FOR GENOME SEQUENCING
DNA SEQUENCING METHODS AND STRATEGIES FOR GENOME SEQUENCINGDNA SEQUENCING METHODS AND STRATEGIES FOR GENOME SEQUENCING
DNA SEQUENCING METHODS AND STRATEGIES FOR GENOME SEQUENCING
 
C dna
C dnaC dna
C dna
 
Sts
StsSts
Sts
 
Genome annotation
Genome annotationGenome annotation
Genome annotation
 
cDNA synthesis
cDNA synthesiscDNA synthesis
cDNA synthesis
 
Vectors
VectorsVectors
Vectors
 
MICROARRAY
MICROARRAYMICROARRAY
MICROARRAY
 
Single Nucleotide Polymorphism (SNP)
Single Nucleotide Polymorphism (SNP)Single Nucleotide Polymorphism (SNP)
Single Nucleotide Polymorphism (SNP)
 
Synthesis of c dna
Synthesis of c dnaSynthesis of c dna
Synthesis of c dna
 
Phage display
Phage displayPhage display
Phage display
 
Long non coding rna
Long non coding rnaLong non coding rna
Long non coding rna
 
DNA Sequencing
DNA SequencingDNA Sequencing
DNA Sequencing
 
Telomere replication
Telomere replicationTelomere replication
Telomere replication
 
Presentation on marker genes
Presentation on marker genesPresentation on marker genes
Presentation on marker genes
 
Expressed sequence tag (EST), molecular marker
Expressed sequence tag (EST), molecular markerExpressed sequence tag (EST), molecular marker
Expressed sequence tag (EST), molecular marker
 
Rapid amplification of c-DNA ends
Rapid amplification of c-DNA endsRapid amplification of c-DNA ends
Rapid amplification of c-DNA ends
 
Crispr cas9
Crispr cas9Crispr cas9
Crispr cas9
 
DNA footprinting
DNA footprintingDNA footprinting
DNA footprinting
 

Degenerate primer

  • 1. DESIGNING DEGENERATE PRIMERS • Degenerate primers may be used to amplify DNA in situations where only the protein sequence of a gene is known, or where the aim is to isolate similar genes from a variety of species. • A six or seven residue peptide sequence should be selected, corresponding to an oligo of about 20 nucleotides. • If the oligo is designed to amplify several similar protein sequences, then the most conserved regions of the proteins need to be selected. If some of the residues are not completely conserved, then the oligo sequence will need to accommodate all possible codons of all amino acid residues at that site (e.g. if one protein has an E at a particular site, while all the others have a D, then the corresponding oligo sequence will be GAN – see table overleaf). • The peptide sequence should avoid amino acids that have a lot of codons, such as leucine (L), arginine (R), and serine (S). Instead, aim for regions that are rich in amino acids that have only one or two possible codons (i.e. M, W, C, D, E, F, H, K, N, Q, Y – see table overleaf). • Inosine residues can pair with any nucleotide, and so can be used at sites where there is complete degeneracy (i.e. substitute I for N in the table below). This reduces the number of oligos that have to be synthesised. Note that only some manufacturers use inosine, however. • Try and avoid degeneracy at the 3’ end of the oligo (note that it is not necessary to have whole codons), and especially avoid ending in inosine. • The table overleaf may be used to help with primer design: amino acid amino acid symbol nucleotide sequence (with complement (for designing reverse
  • 2. degeneracy) primers) methionine M ATG TAC tryptophan W TGG ACC cysteine C TGY ACR aspartic acid D GAY CTR glutamic acid E GAR CTY phenylalanine F TTY AAR histidine H CAY GTR lysine K AAR TTY asparagine N AAY TTR glutamine Q CAR GTY tyrosine Y TAY ATR inosine I ATH TAD alanine A GCN CGN glycine G GGN CCN proline P CCN GGN threonine T ACN TGN valine V GTN CAN leucine L YTN RAN arginine R MGN KCN serine S WSN WSN Key to symbols: R = A + G Y = C + T M = A + C K = G + T S = G + C W = A + T H = A + T + C D = G + A + T B = G + T + C V = G + A + C N = A + T + G + C